Jan 19 2025 106 mins 3
In this episode of The Sunday Roast, Phil Carroll, Kevin Hornsby, and Charles Archer welcome two special guests. James Short, CEO of Celadon Pharmaceuticals, discusses the company’s strategic collaboration with Valeos Pharma and its significant European contract driving growth in the cannabis-based medicines sector. Sean Smith, CEO of Eden Research, delves into their innovative biopesticides and how these products are shaping sustainable agriculture. Alongside these insightful interviews, the team delivers their usual roundup of the week’s biggest news stories, market movers, and the lively stock market banter you’ve come to expect.
00:00 - 00:16:19 Weekly News Roundup
00:16:19 #EDEN Interview
00:52:05 #CEL Interview
01:20:39 #BANK
01:22:42 #BLU
01:23:42 #ARCM #GMET #JLP #AMRQ
01:25:00 #PREM
01:27:16 #M&A
01:29:59 #TM1
01:39:36 TV recommendations
Disclaimer & Declaration of Interest
This podcast may contain paid promotions, including but not limited to sponsorships, endorsements, or affiliate partnerships. The information, investment views, and recommendations provided are for general informational purposes only and should not be construed as a solicitation to buy or sell any financial products related to the companies discussed. Any opinions or comments are made to the best of the knowledge and belief of the commentators; however, no responsibility is accepted for actions based on such opinions or comments. The commentators may or may not hold investments in the companies under discussion. Listeners are encouraged to perform their own research and consult with a licensed professional before making any financial decisions based on the content of this podcast.
00:00 - 00:16:19 Weekly News Roundup
00:16:19 #EDEN Interview
00:52:05 #CEL Interview
01:20:39 #BANK
01:22:42 #BLU
01:23:42 #ARCM #GMET #JLP #AMRQ
01:25:00 #PREM
01:27:16 #M&A
01:29:59 #TM1
01:39:36 TV recommendations
Disclaimer & Declaration of Interest
This podcast may contain paid promotions, including but not limited to sponsorships, endorsements, or affiliate partnerships. The information, investment views, and recommendations provided are for general informational purposes only and should not be construed as a solicitation to buy or sell any financial products related to the companies discussed. Any opinions or comments are made to the best of the knowledge and belief of the commentators; however, no responsibility is accepted for actions based on such opinions or comments. The commentators may or may not hold investments in the companies under discussion. Listeners are encouraged to perform their own research and consult with a licensed professional before making any financial decisions based on the content of this podcast.
